Abstract
The pancreas and the gallbladder are known as the principal target organs of cholecystokinin (CCK) in the gastrointestinal tract. However, CCK receptors are located throughout the entire gut, having been identified on smooth muscle cells of the esophagus, stomach, small intestine, and colon [1]. Therefore it is conceivable that CCK is also involved in physiological modulation of gastrointestinal motility.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Walsh JH (1987) Gastrointestinal hormones. In: Johnson LR (ed) Physiology of the gastrointestinal tract. Raven, New York, pp 181–253
Makovec F, Christe R, Bani M, Pacini MA, Setnikar I, Rovati LA (1985) New glutaramic acid derivatives with potent competitive and specific cholecystokinin-antagonistic activity. Arzneimittelforschung 35:1048–1051
Setnikar I, Bani M, Cereda R, Christé R, Makovec F, Pacini MA, Revel L (1987) Anticholecystokinin activities of loxiglumide. Arzneimittelforschung 37: 1168–1171
Resin H, Stern DH, Sturdevant RAL, Isenberg JI (1973) Effect of the C-terminal octapeptide of cholecystokinin on lower esophageal sphincter pressure in man. Gastroenterology 64:946–949
Sturdevant RAL, Kun T (1974) Interaction of pentagastrin and the octapeptide of cholecystokinin on the human lower esophageal sphincter. Gut 15:700–702
Fisher RS, DiMarino AJ, Cohen S (1975) Mechanism of cholecystokinin inhibition of lower esophageal sphincter pressure. Am J Physiol 228:1469–1473
Dodds WJ, Dent J, Hogan WJ, Patel GK, Toouli J, Arndorfer RC (1981) Paradoxical lower esophageal sphincter contraction induced by cholecystokinin-octapeptide in patients with achalasia. Gastroenterology 80:327–333
Nebel OT, Castell DO (1972) Lower esophageal sphincter pressure changes after food ingestion. Gastroenterology 63:778–783
Liddle RA, Goldfine ID, Rosen MS, Taplitz RA, Williams JA (1985) Cholecystokinin bioactivity in human plasma: molecular forms, responses to feeding, and relationship to gallbladder contraction. J Clin Invest 75:1144–1152
Brazer SR, Borislow DS, Liddle RA (1990) Cholecystokinin is not a major hormonal regulator of lower esophageal sphincter pressure. Gastroenterology 99:641–645
Katschinski M, Koppelberg T, Wank U, Adler G, Rovati LC, Arnold R (1990) CCK plays a role as a physiological regulator of human esophageal motility (Abstr). J Gastrointest Motil 2:148
Biancani P, Walsh JH, Behar J (1984) Vasoactive intestinal polypeptide: a neurotransmitter for lower esophageal sphincter relaxation. J Clin Invest 73: 963–967
Biancani P, Beinfeld MC, Hillemeier C, Behar J (1989) Role of peptide histidine isoleucine in relaxation of cat lower esophageal sphincter. Gastroenterology 97:1083–1089
Rattan S, Goyal RK (1986) Structure-activity relationship of subtypes of cholecystokinin receptors in the cat lower esophageal sphincter. Gastroenterology 90:94–102
Behar J, Biancani P (1977) Effect of cholecystokinin-octapeptide on lower esophageal sphincter. Gastroenterology 73:57–61
Aggestrup S, Uddman R, Jensen SL, Hakanson R, Sundler F, Schaffalitzky de Muckadell O, Emson P (1986) Regulatory peptides in lower esophageal sphincter of pig and man. Dig Dis Sci 31:1370–1375
Chey WY, Hitanant S, Hendricks J, Lorber SH (1970) Effect of secretin and cholecystokinin on gastric emptying and gastric secretion in man. Gastroenterology 58:820–827
Valenzuela JE, Defilippi C (1981) Inhibition of gastric emptying in humans by secretin, the octapeptide of cholecystokinin, and intraduodenal fat. Gastroenterology 81:898–902
Konturek SJ, Kwiecien N, Obtulowicz W, Kopp B, Oleksy J, Rovati L (1990) Cholecystokinin in the inhibition of gastric secretion and gastric emptying in humans. Digestion 45:1–8
Liddle RA, Morita ET, Conrad CK, Williams JA (1986) Regulation of gastric emptying in humans by cholecystokinin. J Clin Invest 77:992–996
Kleibeuker JH, Beekhuis H, Jansen JBMJ, Piers DA, Lamers CBHW (1988) Cholecystokinin is a physiological hormonal mediator of fat-inhibition of gastric emptying in man. Eur J Clin Inv 18:173–177
Liddle RA (1989) Integrated actions of cholecystokinin on the gastrointestinal tract: use of the cholecystokinin bioassay. Gastroenterol Clin North Am 18: 135–756
Scarpignato C, Zimbaro G, Vitulo F, Bertaccini G (1981) Caerulein delays gastric emptying of solids in man. Arch Int Pharmacodyn Ther 249:98–105
Hasler W, Bowling B, Owyang C (1989) Intraduodenal lipids induce pyloric contractions: role of cholecystokinin and the cholinergic and opiate pathways (Abstr). Gastroenterology 96:A200
Fraser R, Fone D, Horowitz M, Dent J (1990) Dose related stimulation of pyloric motility in humans by cholecystokinin octapeptide (Abstr). Gastroenterology 98:A351
Corazziari E, Ricci R, Biliotti D, Bontempo I, Pallotta N, Torsoli A (1990) Oral administration of CCK antagonist loxiglumide inhibits postprandial gallbladder contraction without affecting gastric emptying. Dig Dis Sci 35:50–54
Niederau C, Mecklenbeck W, Heindges T, Lüthen R (1990) CCK hemmt die Magenentleerung einer regulären Mahlzeit unter physiologischen Bedingungen beim Menschen nicht (Abstr). Z Gastroenterol 28:510
Liddle RA, Gertz BJ, Kanayama S, Beccaria L, Coker LD, Turnbull TA, Morita ET (1989) Effects of a novel cholecystokinin (CCK) receptor antagonist, MK-329, on gallbladder contraction and gastric emptying in humans: implications for the physiology of CCK. J Clin Invest 84:1220–1225
Meyer BM, Werth BA, Beglinger C, Hildebrand P, Jansen JBMJ, Zach D, Rovati LC, Stalder GA (1989) Role of cholecystokinin in regulation of gastrointestinal motor functions. Lancet 2:12–15
Green T, Dimaline R, Dockray GJ (1989) Neuroendocrine control mechanisms of gastric emptying in the rat. In: Singer MV, Goebell H (eds) Nerves and the gastrointestinal tract. MTP, Lancaster, pp 433–445
Moran T, Smith GP, Hostetler AM, McHugh PR (1987) Transport of cholecystokinin (CCK) binding sites in subdiaphragmatic vagal branches. Brain Res 415:149–152
Allescher HD, Daniel EE, Fox JET, Kostolanska F, Rovati LA (1989) Effect of the novel cholecystokinin receptor antagonist CR-1392 on cholecystokinin-induced antroduodenal and pyloric motor activity in vivo. J Pharmacol Exp Ther 251:1134–1141
Telford GL, Mir SS, Mason GR, Ormsbee HS III (1979) Neural control of canine pylorus. Am J Surg 137:92–98
Kuwahara A, Ozawa K, Yanaihara N (1986) Effects of cholecystokinin-octapeptide on gastric motility of anesthetized dogs. Am J Physiol 251: G678–G681
Vizi E, Bertaccini G, Implicciatore M, Knoll J (1973) Evidence that acetylcholine release by gastrin and related polypeptides contributes to their effect on gastrointestinal motility. Gastroenterology 64:268–277
Scheurer UL, Varga L, Drack E, Burki HR, Halter F (1983) Mechanisms of action of CCK-octapeptide on rat antrum, pylorus, and duodenum. Am J Physiol 244:G266–G272
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1991 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Katschinski, M. (1991). The Role of CCK and CCK Antagonists in Human Esophageal and Gastroduodenal Motility. In: Adler, G., Beglinger, C. (eds) Cholecystokinin Antagonists in Gastroenterology. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-76362-5_18
Download citation
DOI: https://doi.org/10.1007/978-3-642-76362-5_18
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-76364-9
Online ISBN: 978-3-642-76362-5
eBook Packages: Springer Book Archive